top of page

Our Scientific & Advisory Board

Our Scientific & Advisory Board brings together internationally recognised experts in neurology, genetics, neuroscience and translational research, providing strategic scientific guidance to accelerate the development of effective therapies for SLC6A1-related neurodevelopmental disorder (SLC6A1-NDD).

​

​

Elena Bossi

Elena B..png

Elena Bossi is an Associate Professor of Physiology at the University of Insubria in Varese, Italy.

 

She holds a PhD in Physiology and leads research on ion channels and membrane transporters, with a particular focus on the cellular and molecular mechanisms underlying neuronal communication.

 

She heads the Laboratory of Cellular and Molecular Physiology and has authored numerous peer-reviewed publications in leading international scientific journals.

Katrine M. Johannesen

katrine Johannesen.jpg

Katrine M. Johannesen, MD, PhD, is a neurologist, clinical geneticist, and clinical researcher at the Danish Epilepsy Centre and Rigshospitalet in Copenhagen, Denmark.

 

Her work focuses on genetic epilepsies, with particular expertise in rare disorders caused by variants in genes such as SCN8A, SLC6A1, and other epilepsy-associated genes.

 

She is actively involved in international research collaborations aimed at improving the understanding, diagnosis, and treatment of rare genetic epilepsies.

Ángel Aledo-Serrano

Angel-Aledo-Serrano.webp

Ángel Aledo-Serrano, MD, PhD, is a neurologist and epileptologist and Director of the Vithas Clinical Neuroscience Institute in Madrid, Spain.

 

He specializes in the diagnosis and treatment of rare and complex epilepsies, with a particular interest in clinical neurogenetics and precision medicine.

 

He leads and coordinates international clinical research focused on early diagnosis and the development of innovative therapies for developmental and epileptic encephalopathies.

Vincenzo Crunelli

vincenzo k..jpg

Vincenzo Crunelli, MD, PhD, is Emeritus Professor of Neuroscience at Cardiff University, United Kingdom.

 

He is internationally recognized for his pioneering research on the physiology of thalamic neurons and the brain rhythms that regulate sleep, attention, and epilepsy.

 

Throughout his career, he has led numerous European research projects and multidisciplinary teams investigating the neurophysiology of sleep and thalamocortical function, making major contributions to our understanding of the mechanisms underlying epilepsy.

Despoina Mandelenaki

despoina.jpg

Despoina Mandelenaki, MD, is a Consultant Paediatric Neurologist at Evelina London Children's Hospital, part of Guy’s and St Thomas’ NHS Foundation Trust in London, United Kingdom.

 

She specializes in the care of children with complex epilepsies and rare neurological disorders.

 

Her clinical and research interests focus on translational neuroscience, multidisciplinary models of care, and improving outcomes for children and families through integrated, patient-centred approaches.

Stephan J. Sanders

Sanders_profile_July2023-1920w.webp

Stephan J. Sanders, BMBS, PhD, is Professor of Psychiatry at the University of California, San Francisco (UCSF), and previously held a faculty position at the University of Oxford.

 

His research combines functional genetics, genomics, and bioinformatics to uncover the biological mechanisms underlying neurodevelopmental disorders, including autism and related conditions.

 

His work focuses on identifying rare genetic variants and translating these discoveries into targeted therapeutic strategies and precision medicine approaches.

Francisco Zafra Gómez

Francisco+Zafra+Gómez.jpg

Francisco Zafra Gómez, PhD, is Professor of Molecular Biology at the Autonomous University of Madrid, Spain.

 

He leads research on the molecular basis of glutamatergic synapses, with a particular focus on the molecular mechanisms of neurotransmission and the function of neurotransmitter transporters.

 

His work has made significant contributions to understanding the fundamental processes that regulate synaptic communication and central nervous system function.

Dennis Lal

Lal-Dennis.jpg

Dennis Lal, PhD, is a clinical neurogenetics researcher at UTHealth Houston and the Cleveland Clinic Lerner College of Medicine.

 

He directs the Center for Neurogenetics, where his research focuses on uncovering the genetic basis of neurological disorders, particularly epilepsy.

 

His work leverages genomic technologies to identify disease mechanisms, develop biomarkers, and advance innovative therapeutic strategies for rare neurological disorders.

bottom of page